Susvimo 50242-0078
Generic: Ranibizumab
Product NDC
50242-0078- Manufacturer
- Genentech, Inc.
- Dosage Form
- Injection, Solution
- Route
- Intravitreal
- Product Type
- Human Prescription Drug
- Marketing Start
- October 22, 2021
- Listing Expires
- December 31, 2026
- Application
- BLA761197
Need to source Susvimo? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Ranibizumab | 100 mg/mL |
Drug Class
Vascular Endothelial Growth Factor Inhibitor [EPC]Vascular Endothelial Growth Factor Inhibitor [EPC]Vascular Endothelial Growth Factor Inhibitors [MoA]
Packaging Options(2)
1 VIAL in 1 CARTON (50242-078-12) / 1 mL in 1 VIAL
1 VIAL in 1 CARTON (50242-078-55) / 1 mL in 1 VIAL